Alan Brian Collier Insider Trading for August 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alan Brian Collier.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Alan Brian Collier for August 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 25,184,297 | 25.2 M to 25.2 M (+0.01 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 25,182,297 | 25.2 M to 25.2 M (+0.01 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 25,180,297 | 25.2 M to 25.2 M (+0.01 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 152 | 25,178,297 | 25.2 M to 25.2 M (+0.06 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 25,163,297 | 25.2 M to 25.2 M (+0.01 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 25,161,297 | 25.2 M to 25.2 M (+0.01 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 210 | 25,159,297 | 25.1 M to 25.2 M (+0.08 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 153 | 25,139,297 | 25.1 M to 25.1 M (+0.06 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 104 | 25,124,297 | 25.1 M to 25.1 M (+0.04 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 155 | 25,114,297 | 25.1 M to 25.1 M (+0.06 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 25,099,297 | 25.1 M to 25.1 M (+0.01 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 104 | 25,097,297 | 25.1 M to 25.1 M (+0.04 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 52 | 25,087,297 | 25.1 M to 25.1 M (+0.02 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 52 | 25,082,297 | 25.1 M to 25.1 M (+0.02 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 25,077,297 | 25.1 M to 25.1 M (+0.01 %) |
| Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 102 | 25,075,297 | 25.1 M to 25.1 M (+0.04 %) |
| Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 25,065,297 | 25.1 M to 25.1 M (+0.02 %) |
| Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 54 | 25,060,297 | 25.1 M to 25.1 M (+0.02 %) |
| Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 25,055,297 | 25.1 M to 25.1 M (+0.02 %) |
| Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 109 | 25,050,297 | 25 M to 25.1 M (+0.04 %) |
| Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 218 | 25,040,297 | 25 M to 25 M (+0.08 %) |
| Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 25,020,297 | 25 M to 25 M (+0.02 %) |
| Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 25,015,297 | 25 M to 25 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 54 | 25,010,297 | 25 M to 25 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 25,005,297 | 25 M to 25 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 22 | 25,000,297 | 25 M to 25 M (+0.01 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 24,998,297 | 25 M to 25 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 24,993,297 | 25 M to 25 M (+0.01 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 24,991,297 | 25 M to 25 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 102 | 24,986,297 | 25 M to 25 M (+0.04 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 500 | 5 | 24,976,297 | 25 M to 25 M (0.00 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 101 | 24,975,797 | 25 M to 25 M (+0.04 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 19,950 | 201 | 24,965,797 | 24.9 M to 25 M (+0.08 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 50 | 1 | 24,945,847 | 24.9 M to 24.9 M (0.00 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 100 | 24,945,797 | 24.9 M to 24.9 M (+0.04 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 51 | 24,935,797 | 24.9 M to 24.9 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 51 | 24,930,797 | 24.9 M to 24.9 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 3,000 | 30 | 24,925,797 | 24.9 M to 24.9 M (+0.01 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 24,922,797 | 24.9 M to 24.9 M (+0.01 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 54 | 25,010,297 | 25 M to 25 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 25,005,297 | 25 M to 25 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 22 | 25,000,297 | 25 M to 25 M (+0.01 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 24,998,297 | 25 M to 25 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 24,993,297 | 25 M to 25 M (+0.01 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 24,991,297 | 25 M to 25 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 102 | 24,986,297 | 25 M to 25 M (+0.04 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 500 | 5 | 24,976,297 | 25 M to 25 M (0.00 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 101 | 24,975,797 | 25 M to 25 M (+0.04 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 19,950 | 201 | 24,965,797 | 24.9 M to 25 M (+0.08 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 50 | 1 | 24,945,847 | 24.9 M to 24.9 M (0.00 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 100 | 24,945,797 | 24.9 M to 24.9 M (+0.04 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 51 | 24,935,797 | 24.9 M to 24.9 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 51 | 24,930,797 | 24.9 M to 24.9 M (+0.02 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 3,000 | 30 | 24,925,797 | 24.9 M to 24.9 M (+0.01 %) |
| Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 24,922,797 | 24.9 M to 24.9 M (+0.01 %) |
| Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 24,920,797 | 24.9 M to 24.9 M (+0.01 %) |
| Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 24,918,797 | 24.9 M to 24.9 M (+0.01 %) |
| Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 24,916,797 | 24.9 M to 24.9 M (+0.01 %) |
| Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 24,914,797 | 24.9 M to 24.9 M (+0.01 %) |
| Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 159 | 24,912,797 | 24.9 M to 24.9 M (+0.06 %) |
| Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 24,897,797 | 24.9 M to 24.9 M (+0.01 %) |
| Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 12,000 | 139 | 24,895,797 | 24.9 M to 24.9 M (+0.05 %) |
| Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 118 | 24,883,797 | 24.9 M to 24.9 M (+0.04 %) |
| Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 177 | 24,873,797 | 24.9 M to 24.9 M (+0.06 %) |